10:31 AM EST - Microbix Biosystems Inc. : Announced attainment of Australian Therapeutic Goods Administration (TGA) registration for its COVID-19 and high-risk HPV quality assessment products (QAPs™) – TGA registration of these REDx™ Controls & REDx™FLOQ® products by Microbix’s distributor, R-Biopharm, enables it to offer these workflow controls to Australian clinical labs. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.27.
